Skip to main content
Anteris Technologies Global Corp. logo

Anteris Technologies Global Corp. — Investor Relations & Filings

Ticker · AVR ISIN · US03675P1021 ASX Manufacturing
Filings indexed 1,665 across all filing types
Latest filing 2017-03-14 Board/Management Inform…
Country US United States of America
Listing ASX AVR

About Anteris Technologies Global Corp.

https://anteristech.com/

Anteris Technologies is a structural heart company focused on the development and commercialization of medical devices for heart valve disease. Its lead product is the DurAVR® Transcatheter Heart Valve (THV), a biomimetic valve designed for patients with severe aortic stenosis. The DurAVR® THV is engineered to mimic the performance of a healthy human aortic valve, aiming to restore normal, laminar blood flow. Clinical studies have shown the device delivers a favorable hemodynamic profile, characterized by low pressure gradients and a significant reduction in prosthesis-patient mismatch (PPM), even in patients with challenging anatomies. The company is advancing its technology through pivotal clinical trials to establish a new standard in transcatheter aortic valve replacement (TAVR) and improve long-term patient outcomes.

Recent filings

Filing Released Lang Actions
Admedus Appoints Wayne Paterson as CEO 3 pages 419.0KB
Board/Management Information Classification · 100% confidence The document is an ASX announcement from Admedus Limited dated March 15, 2017, announcing the appointment of Wayne Paterson as Chief Executive Officer. It details his background, the board's decision, and remuneration terms. There are no financial statements, quarterly or annual results, or detailed financial data. The content focuses on management changes at the executive level. Therefore, this document fits the category of Board/Management Information (MANG). The document length is 7,371 characters, which is sufficient for a full announcement rather than a brief note or report publication announcement.
2017-03-14 English
Admedus Appoints John Seaberg as Chairman 2 pages 412.5KB
Board/Management Information Classification · 100% confidence The document is an ASX announcement from Admedus Limited dated March 14, 2017, announcing the appointment of John Seaberg as Chairman. It details his background, the reason for the appointment, and includes contact information and company background. There is no financial data, no report or results, no voting results, no regulatory certifications, or other report publication notices. The content is clearly about a change in senior management, specifically the Chairman position. Therefore, this fits the category of Board/Management Information (MANG). The document length is about 5253 characters, which is sufficient for a detailed announcement but not a full report.
2017-03-13 English
Shareholder Webinar Presentation 49 pages 4.4MB
Investor Presentation Classification · 95% confidence The document is a detailed presentation titled 'Mid Year Results and Business Update February 2017' from Admedus Ltd. It contains extensive financial performance data, business updates, strategic plans, product pipeline information, and market analysis. The content includes sales figures, gross profit increases, cost savings, clinical trial updates, and strategic initiatives. The document is about 15,000 characters long, indicating it is a full presentation rather than a brief announcement. It is not a formal annual or interim report with full financial statements, nor is it a transcript of a call or a regulatory filing. The document is clearly a presentation aimed at investors and stakeholders, focusing on financials, strategy, and market position. Therefore, it fits best into the category of Investor Presentation (IP).
2017-02-27 English
Approval and first sales in Saudi Arabia 2 pages 446.1KB
Regulatory Filings Classification · 95% confidence The document is a company announcement about receiving regulatory approval and initial sales in Saudi Arabia for a product. It is a press release style update on business development and market expansion, not a financial report or detailed regulatory filing. The text is relatively short (3536 characters) and does not contain financial statements, management discussion, or detailed data. It does not fit categories like Annual Report, Interim Report, Earnings Release, or Regulatory Filings. It is a general company announcement about a business milestone and market approval, which aligns best with the Regulatory Filings (RNS) category as a general announcement that does not fit other specific categories.
2017-02-27 English
Admedus Announces Half Yearly Report 5 pages 632.5KB
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Admedus Limited Half Year Financials Report (Appendix 4D) for the six months ended 31 December 2016' and contains detailed financial data including revenue, gross profit, EBITDA, segment revenues, and business outlook for the half year period. It includes a Directors' Report, Financial Report, Directors' Declaration, and Audit Report and Independence Declaration, which are typical components of an interim or half-year financial report. The presence of actual financial statements and substantive financial data confirms it is a comprehensive interim report rather than a brief announcement or certification. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). H1 2017
2017-02-23 English
Half Yearly Report and Accounts 26 pages 765.3KB
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Appendix 4D Half Yearly Report' and includes detailed financial data for the half-year ended 31 December 2016, including consolidated statements of profit or loss and other comprehensive income. It contains comprehensive financial performance information, directors' reports, auditor's independence declaration, and detailed commentary on operations and results for the half-year period. The presence of actual financial statements and substantive financial data for a period shorter than a full fiscal year clearly indicates this is an Interim / Quarterly Report. The document length (15,000 characters) and detailed content confirm it is the report itself, not just an announcement or summary. H1 2017
2017-02-23 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.